drugset

drugset / Trial / NCT02374814

Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis

NCT02374814 ↗

Phase 4 Completed 60 enrolled State University of New York - Upstate Medical University Walter Reed Army Institute of Research (WRAIR) · collab

RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to compare the effectiveness of a two dose versus a three dose schedule and intramuscular versus intradermal injection for pre-exposure prophylaxis.

Timeline

Start: 2015-03-24
Primary completion: 2016-09-22
Completion: 2016-09-22

Publications

Results Endy TP, Keiser PB, Wang D, Jarman RG, Cibula D, Fang H, Ware L, Abbott M, Thomas SJ, Polhemus ME. Serologic Response of 2 Versus 3 Doses and Intradermal Versus Intramuscular Administration of a Licensed Rabies Vaccine for Preexposure Prophylaxis. J Infect Dis. 2020 Apr 7;221(9):1494-1498. doi: 10.1093/infdis/jiz645.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rabies vaccine	Vaccine	0.1 ml	Intramuscular
Subject	Rabies vaccine	Vaccine	1 ml	Intramuscular

Indications